A post hoc analysis of the COAPT trial suggests that transcatheter mitral valve repair for secondary mitral regurgitation is efficacious in patients with heart failure and chronic kidney disease. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results